Clinical Trials on Human Chorionic Gonadotrophin

Total 29744 results

Protalix

Completed

Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers

Human Volunteer

Israel
Bayer

Completed

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

Human Experimentation
Pfizer

Completed

Drug-Drug Interaction Study Of Effect Of PF-03882845 On Simvastatin Pharmacokinetics

Human Volunteers

Singapore
NeurogesX

Completed

Effect of NGX-4010 on ENFD and Sensory Function

Human Volunteers

United States
Evotec Neurosciences GmbH
Richmond Pharmacology Limited

Completed

The Effects of a Novel NMDA NR2B-Subtype Selective Antagonist, EVT 101, on Brain Function

Human Volunteers

United Kingdom
Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Recruiting

Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects (XT1061)

Chronic Hepatitis b

China
Chinese University of Hong Kong

Recruiting

Prospective Evaluation of a Fast-track Treatment Pathway for Patients With Chronic Hepatitis B Under Primary Care

Chronic Hep B

Hong Kong
Korea University
Yonsei University; Inje University; The Catholic University of Korea; CHA University and other collaborators

Unknown

Tenofovir Combination or Mono-therapy for MDR CHB

Chronic Hepatitis b With Multidrug Resistance

Korea, Republic of
Zhujiang Hospital
Zhongshan Bo Ai Hospital

Active, not recruiting

Effects of IAP-EOGBSD on Maternal Vaginal Microbiome, Offspring's Gut Microbiome and Metabolites.

Microbiome, Human

China
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Study of Gardasil in Mid-Adult Males (MAM)

Human Papillomavirus

United States, Mexico
Laval University

Completed

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Human Papillomavirus

Canada
University of Latvia
Latvian Biomedical Research and Study Centre

Enrolling by invitation

Effects of H.Pylori Eradication on Microbiome

Human Microbiome

Latvia
University Hospital, Toulouse

Completed

Detection of Human Papillomavirus in Polymerase Chain for Suspicious Lesions of the Amygdala: Concordance Smear-Biopsy (HPV-BIOFRO)

Human Papillomavirus

France
Pfizer

Completed

Study of BMN 673, a PARP Inhibitor, in Healthy Adult Male Volunteers

Human Volunteers

United States
Bispebjerg Hospital

Completed

Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance

Human Volunteers

Denmark
University of North Carolina, Chapel Hill
Harvard Medical School (HMS and HSDM); Pfizer; North Carolina Department of Health...

Completed

Making Effective Human Papillomavirus (HPV) Vaccine Recommendations

Human Papillomavirus

United States
Pfizer

Completed

A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects

Human Volunteers

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.

Human Volunteers
Universal Enterprises

Unknown

Bioequivalence of Phenazopyridine HCl in Healthy Volunteers

Human Volunteers

Pakistan
Gilead Sciences

Completed

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Chronic Hepatitis Delta

France, Moldova, Republic of, Romania, Russian Federation
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers

Chronic Hepatitis B

China
Phillip Coffin, MD, MIA
National Institute on Drug Abuse (NIDA)

Completed

Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs (BYE-C)

Chronic Hepatitis C

United States
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects (HEC110114)

Chronic Hepatitis C

China
Ascletis Pharmaceuticals Co., Ltd.

Completed

Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.

HCV

China
Sunshine Lake Pharma Co., Ltd.

Completed

The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult Subjects (HEC110114)

Chronic Hepatitis C

China
Chang Gung Memorial Hospital

Completed

Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy

Chronic Hepatitis B

Taiwan
Transgene

Completed

Safety and Tolerability of TG1050: A Dose-finding Study

Chronic Hepatitis B

France, Canada, Germany
American Research Corporation
AbbVie

Completed

A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study (HEARTLAND)

Chronic Hepatitis C
Fundacion SEIMC-GESIDA

Withdrawn

A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A (C-RESCUE)

HCV

Spain
Shanghai HEP Pharmaceutical Co., Ltd.

Completed

Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers

Hepatitis B， Chronic

China
Shanghai HEP Pharmaceutical Co., Ltd.

Completed

Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers

Hepatitis B， Chronic

China
Merck Sharp & Dohme LLC

Terminated

Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects

Chronic Hepatitis C
Merck Sharp & Dohme LLC

Completed

A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

Chronic Hepatitis C
IlDong Pharmaceutical Co Ltd

Completed

Bioequivalence Study to Compare the Pharmacokinetics of Besifovir in Healthy Adult Volunteers

Chronic Hepatitis B
Ruijin Hospital

Unknown

Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients

Chronic Hepatitis B

China
Bristol-Myers Squibb

Completed

A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

Chronic Hepatitis C

United States, Argentina
Nanfang Hospital of Southern Medical University
Major Science and Technology Special Project of China 12th Five-year

Unknown

3E Extension Study (3E Ex)

Chronic Hepatitis B

China
Korea University
GlaxoSmithKline

Completed

Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) (ALTER)

Chronic Hepatitis B

Korea, Republic of
Gilead Sciences

Completed

A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

Chronic Hepatitis C

United States, Puerto Rico
Bukwang Pharmaceutical

Completed

Long-term Study With Clevudine

Chronic Hepatitis B

Korea, Republic of
Vertex Pharmaceuticals Incorporated

Completed

A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects

Chronic Hepatitis C

United States
Bristol-Myers Squibb

Completed

A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Chronic Hepatitis C

United States
Arrow Therapeutics
DDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New Zealand

Terminated

A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers (CP104)

Chronic Hepatitis C

New Zealand, United Kingdom
Foundation for Liver Research

Completed

Long Term Follow-up of Pegylated-Interferon Alpha-2b

Chronic Hepatitis B

Netherlands
Xingfei Pan

Enrolling by invitation

Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV

Chronic Hepatitis b | Women

China
José Antonio Carrion
Instituto de Salud Carlos III

Completed

HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients

Chronic Hepatitis B (HBeAg-negative)
Merck Sharp & Dohme LLC

Completed

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

Chronic Hepatitis C Infection
Kaiser Permanente
National Cancer Institute (NCI)

Recruiting

Provider Recommendation and HPV Vaccination (HPVV)

Human Papillomavirus

United States
Mayo Clinic

Recruiting

Implications of the Human Microbiota for Health and Disease

Human Microbiota

United States
University Medical Center Groningen

Completed

Microbiome Composition Changes on 4 Week Gluten-free Diet Challenge

Human Microbiome

Netherlands

3

Subscribe